128
Views
0
CrossRef citations to date
0
Altmetric
Articles

Recapitulate genistein for topical applications including nanotechnology delivery

, , , , &
Pages 1306-1317 | Received 16 Jun 2021, Accepted 16 Jan 2022, Published online: 15 Mar 2022
 

Abstract

Genistein is one of the natural isoflavones. It is a phytoestrogen having several pharmacological characteristics. It inhibited tyrosine and topoisomerase. That resulted in inhibition of cell proliferation and death of cancerous cells. In general the aging or cutaneous changes in females are linked with estrogen level. This can be reversed by given estrogen supplementation. Estrogen deficiency in postmenopausal women linked to atrophy, dehydration, fine wrinkling, and poor wound healing. Genistein and some other isoflavones bind to estrogen receptors and improve skin changes. This study focuses on the benefits of genistein and other isofavones on skin safety and healing in various skin disorders. As and when genistein administered topically in the form of creams (anti-wrinkle, skin tone, anti-skin aging, day, and night), face masks, micellar water, and other dosage forms based on nanotechnology.

Acknowledgments

All the authors are pleased to Integral University for given that technical prop up and assigning communiqué reference no. IU/R&D/2022-MCN0001395, for further communication.

Additional information

Funding

All the authors are pleased to Integral University for given that technical prop up and assigning communiqué reference no. IU/R&D/2022-MCN0001395, for further communication.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.